In a recurrent leiomyosarcoma study [92], analysis of DNA exon sequences, RNA and protein expression, and transcription factor binding in sarcomas and unaffected muscles and bones revealed that the cause of the disease was a point mutation S181G in FAF1, which may lead to loss of apoptotic function following transformed DNA damage. Here, FAF1 is linked to leiomyosarcoma.